Posters

Conferences Posters

China´s new foreign investment law. business opportunities and challenges at the market.

: Zulaine Guerra Montané
The Foreign Investment Law (FIL) approved on January 1st, 2020 at People Republic of China aims to further open China’s market, encourage foreign investment flows, enhance investment protection and regulate the administration of foreign investments. FIL replaces the so-called ‘three laws on foreign invested enterprises (FIEs)’: the Law of the PRC on Chinese-Foreign Equity Joint Ventures (EJVL), the Law of the PRC on Chinese-Foreign Contractual Joint Ventures (CJVL) and the Law of the PRC on Wholly Foreign-Owned Enterprises (WFEL. Along with this review of the country´s foreign investment regimes, new opportunities open up to overseas investors, who must be timely enough to take advantage of them and also be willing to overcome the challenges that any legal modification of such magnitude brings with it.
Download

The Cuban biopharmaceutical industry and Cuban medical technology in times of Covid-19. Reflection from the science of management.

: Vivian Isabel Antunes
The current context has imposed on biopharmaceutical and medical devices organizations a change in their management systems, strategies and work system. Specifically in the case of Cuba, this sector is an example where a strong strategic focus, innovation, process management, risks, quality and productive chain is manifested. The article aims to reflect on the actions developed by this sector from the Science of Management, through an analysis of the specialized bibliography, the written press and the experiences shown on national television about the intense work of this sector during the COVID-19’s pandemic.
Download

Aspectos sobre la regulación sanitaria global para las vacunas anti COVID-19

: Javier E. Vazquez Romero
Los años 2020 y 2021 han sido determinantes en el diagnóstico y el tratamiento de las COVID-19. La categoría de pandemia, declarada por el presidente de la Organización Mundial de la Salud el 11 de marzo del 2020 para dicha enfermedad, abrió una importante oportunidad, tanto a las empresas farmacéuticas como a otras instituciones científicas y de salud, de participar en la carrera para desarrollar vacunas contra el agente etiológico de la misma, el virus SARS-CoV-2.
Download

Vaccine candidate against SARS-CoV-2 infection.  Immunogenicity and antigenicity strategic.

: Mabel Izquierdo
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has developed into a global pandemic since its first outbreak in the winter of 2019. Several manufacture development vaccine candidates in different expression systems. We developed a candidate in the expression system yeast Pichia pastori having as active principle the Receptor- Binding Domain (RBD) in S protein that contains multiple conformational -dependent epitopes that induces potent neutralizing antibodies against SARS - CoV2 infection. An analytical strategy for the evaluation of immunogenicity and antigenicity was developed to be used during the life cycle of the product. Biological methods as animals testing, immunochemical test (ELISA and others) were used during characterization studies of immunoresponse, stability studies and evaluate the integrity of the vaccine.
Download

Índice egf/monocito: en fusión de evidencias sobre su potencial como nuevo biomarcador de inflamación

: Héctor José Pérez Hernández
La replicación activa del SARS-CoV-2 y una potente respuesta inflamatoria, está asociada a un peor pronóstico de la COVID-19. El papel de los monocitos en la respuesta inflamatoria está sustentado por múltiple evidencia experimental, sin embrago su uso en la práctica médica es infrecuente. Por otro lado el rol del EGF en el marco de la infamación, a pesar de la información disponible sobre el efecto del EGFR en este sentido, es una materia no explorada. Poder disponer de un biomarcador alternativo para evaluar la inflamación podría contribuir a una mejor práctica médica.
Download

UMELISA® EGF: inmunoensayo enzimático para la determinación del factor de crecimiento epidémico (EGF) en muestras de suero humano utilizando un sistema ultramicroanalítico

: Elisa María Castell
El factor de crecimiento epidérmico humano (hEGF) es un péptido pequeño que consta de 53 residuos de aminoácidos, que estimula la proliferación celular y está asociado con varios carcinomas humanos. El cáncer de pulmón de células no pequeñas (NSCLC) es una de las enfermedades malignas más comunes con una alta tasa de mortalidad en todo el mundo. CIMAvax-EGF® es una vacuna terapéutica, segura, registrada en Cuba para NSCLC avanzado, pero no todos los pacientes responden a ella. Sabiendo que la concentración de hEGF en sueros de pacientes con NSCLC tratados con quimioterapia es un biomarcador predictivo de respuesta, es crucial identificar el subconjunto de pacientes elegibles para el tratamiento, para lograr la individualización de la terapia y la mejora de la supervivencia general y el manejo clínico.
Download
12345678910111213141516171819202122

You may also be interested

Special Sessions
My Agenda
Sponsorship
Finlay institute of vaccines signs a memorandum of understanding with an Italian company for the production of Soberana 02
29/ 4/ 22, 11:26 AM
An agreement to start the production of the Sovereign 02 vaccine in the final stages in Italy was signed today between the Finlay Institute of Vaccines (IFV), the Italian company ADIENNE Pharma & Biotech and the Italian Agency for economic and cultural exchange with Cuba (AICEC). ), in the context of the BioHabana 2022 congress. […]
visitar
Cuban vaccine against lung cancer centers scientific collaboration between the CIM and the Roswell Park Institute, New York
29/ 4/ 22, 11:16 AM
The Cuban vaccine against lung cancer, CIMAvax-EGF®, developed by the Center for Molecular Immunology (CIM), continues to expand its horizons both in therapeutic indications and in scientific collaboration, while remaining the core of joint research between the CIM and the Roswell Park Institute, New York, in the United States. This was confirmed to Cubadebate by […]
visitar
ETI Solution for information management of Immunological Studies
29/ 4/ 22, 10:57 AM
visitar
International Immunology Day
29/ 4/ 22, 10:43 AM
Immunology is a SPECIALTY of multidisciplinary scope, which transits through health prevention through immunization, diagnosis and highly specialized medical care. It is a fundamental tool when undertaking first-class biomedical research projects, whose results provide new knowledge and generate effective and innovative products and technologies. In general, immunologically-based diseases are of progressive course, in many cases […]
visitar
NeuroEPO advances in favor of memory
29/ 4/ 22, 10:31 AM
One of the most promising products that the Center for Molecular Immunology (CIM) has today is NeuroEPO, a neuroprotective drug that was obtained last March by the Cuban regulatory agency, the Center for State Control of Medicines, Equipment and Medical Devices (Cecmed) a conditional health registration for the indication of mild and moderate Alzheimer’s disease. […]
visitar
Clinical study with Mambisa in convalescents: Antibody titers increased at least fourfold in most subjects
28/ 4/ 22, 12:53 PM
Dr. Gerardo Guillén Nieto, director of Biomedical Research at the Center for Genetic Engineering and Biotechnology (CIGB), reported that the study included 1,041 convalescent volunteers with at least two months of recovery and up to more than a year and a half of having contracted the disease. It had two research arms: one where half of the sample received the Abdala vaccine, and the other half a single booster dose of the Mambisa vaccine candidate.
visitar
Infantix, the system developed by CNEURO for the detection of hearing and vision disorders
28/ 4/ 22, 9:12 AM
For the first time in the context of neonatal screening, a system allows recording of visual evoked potentials, providing an objective assessment of the visual pathway in a few minutes. This same system is aimed at the objective detection of hearing disorders through the recording and analysis of automatic brainstem auditory evoked potentials and otoacoustic emissions. Its features also make it possible to differentiate between transient and permanent conductive losses due to neural damage.
visitar
Prime Minister of Dominica highlights what Cuban biotechnology could achieve without the blockade
28/ 4/ 22, 8:58 AM
Roosevelt Skerrit, Prime Minister of the Commonwealth of Dominica, visited the BioHabana 2022 trade fair this afternoon at the Havana Convention Center, where he received information on the products of the Cuban biotechnology industry. He was particularly interested in the Cuban vaccines against COVID-19, developed and produced in the country, and which have allowed in a short time to advance in the immunization of the Cuban population.
visitar
Minister of Health: “The best responses to combat COVID-19 have been born from science”
27/ 4/ 22, 5:20 PM
“Covid-19 has represented the greatest challenge for science in recent decades. Never before have so many scientists, professionals, and experts investigated the same topic so intensely and in such a short period of time,” said the Minister of Health, José Angel Portal Miranda, in a keynote address during BioHabana 2022. “Cuba has not been the […]
visitar

Social media